These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 38327444)

  • 21. Comprehensive analysis of vitreous humor chemokines in type 2 diabetic patients with and without diabetic retinopathy.
    Zeng Y; Cao D; Yu H; Hu Y; He M; Yang D; Zhuang X; Zhang L
    Acta Diabetol; 2019 Jul; 56(7):797-805. PubMed ID: 30911832
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Galectin-1 studies in proliferative diabetic retinopathy.
    Abu El-Asrar AM; Ahmad A; Allegaert E; Siddiquei MM; Alam K; Gikandi PW; De Hertogh G; Opdenakker G
    Acta Ophthalmol; 2020 Feb; 98(1):e1-e12. PubMed ID: 31318490
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vitreous and Serum Concentrations of Vascular Endothelial Growth Factor and Platelet-Derived Growth Factor in Proliferative Diabetic Retinopathy.
    Muhiddin HS; Kamaruddin MI; Ichsan AM; Budu
    Clin Ophthalmol; 2020; 14():1547-1552. PubMed ID: 32606568
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sestrin2 Restricts Endothelial-to-Mesenchymal Transition Induced by Lipolysaccharide via Autophagy.
    Huang R; Liu L; Shen K; Duan C; Fan Z
    J Integr Neurosci; 2024 Jul; 23(7):124. PubMed ID: 39082288
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vitreous Fibronectin and Fibrinogen Expression Increased in Eyes With Proliferative Diabetic Retinopathy After Intravitreal Anti-VEGF Therapy.
    Wei Q; Zhang T; Jiang R; Chang Q; Zhang Y; Huang X; Gao X; Jin H; Xu G
    Invest Ophthalmol Vis Sci; 2017 Nov; 58(13):5783-5791. PubMed ID: 29117316
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased expression of M-CSF and IL-13 in vitreous of patients with proliferative diabetic retinopathy: implications for M2 macrophage-involving fibrovascular membrane formation.
    Yoshida S; Kobayashi Y; Nakama T; Zhou Y; Ishikawa K; Arita R; Nakao S; Miyazaki M; Sassa Y; Oshima Y; Izuhara K; Kono T; Ishibashi T
    Br J Ophthalmol; 2015 May; 99(5):629-34. PubMed ID: 25355804
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of proteins associated with clinical and pathological features of proliferative diabetic retinopathy in vitreous and fibrovascular membranes.
    Klaassen I; de Vries EW; Vogels IMC; van Kampen AHC; Bosscha MI; Steel DHW; Van Noorden CJF; Lesnik-Oberstein SY; Schlingemann RO
    PLoS One; 2017; 12(11):e0187304. PubMed ID: 29095861
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A cross-sectional study of vitreous and serum high mobility group box-1 levels in proliferative diabetic retinopathy.
    Shen Y; Cao H; Chen F; Suo Y; Wang N; Xu X
    Acta Ophthalmol; 2020 Mar; 98(2):e212-e216. PubMed ID: 31421026
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Correlation between ficolin-3 and vascular endothelial growth factor-to-pigment epithelium-derived factor ratio in the vitreous of eyes with proliferative diabetic retinopathy.
    Zheng B; Li T; Chen H; Xu X; Zheng Z
    Am J Ophthalmol; 2011 Dec; 152(6):1039-43. PubMed ID: 21851923
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Atheroprone flow enhances the endothelial-to-mesenchymal transition.
    Lai B; Li Z; He M; Wang Y; Chen L; Zhang J; Yang Y; Shyy JY
    Am J Physiol Heart Circ Physiol; 2018 Nov; 315(5):H1293-H1303. PubMed ID: 30052471
    [TBL] [Abstract][Full Text] [Related]  

  • 31. NLRP3 inflammasome activation is associated with proliferative diabetic retinopathy.
    Loukovaara S; Piippo N; Kinnunen K; Hytti M; Kaarniranta K; Kauppinen A
    Acta Ophthalmol; 2017 Dec; 95(8):803-808. PubMed ID: 28271611
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Endothelial-mesenchymal transition in normal human esophageal endothelial cells cocultured with esophageal adenocarcinoma cells: role of IL-1β and TGF-β2.
    Nie L; Lyros O; Medda R; Jovanovic N; Schmidt JL; Otterson MF; Johnson CP; Behmaram B; Shaker R; Rafiee P
    Am J Physiol Cell Physiol; 2014 Nov; 307(9):C859-77. PubMed ID: 25163519
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased expression of periostin in vitreous and fibrovascular membranes obtained from patients with proliferative diabetic retinopathy.
    Yoshida S; Ishikawa K; Asato R; Arima M; Sassa Y; Yoshida A; Yoshikawa H; Narukawa K; Obika S; Ono J; Ohta S; Izuhara K; Kono T; Ishibashi T
    Invest Ophthalmol Vis Sci; 2011 Jul; 52(8):5670-8. PubMed ID: 21508107
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Endothelial-to-mesenchymal transition contributes to endothelial dysfunction and dermal fibrosis in systemic sclerosis.
    Manetti M; Romano E; Rosa I; Guiducci S; Bellando-Randone S; De Paulis A; Ibba-Manneschi L; Matucci-Cerinic M
    Ann Rheum Dis; 2017 May; 76(5):924-934. PubMed ID: 28062404
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aqueous humor levels of cytokines are related to vitreous levels and progression of diabetic retinopathy in diabetic patients.
    Funatsu H; Yamashita H; Noma H; Mimura T; Nakamura S; Sakata K; Hori S
    Graefes Arch Clin Exp Ophthalmol; 2005 Jan; 243(1):3-8. PubMed ID: 15258777
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Soluble cellular adhesion molecules in proliferative vitreoretinopathy and proliferative diabetic retinopathy.
    Barile GR; Chang SS; Park LS; Reppucci VS; Schiff WM; Schmidt AM
    Curr Eye Res; 1999 Sep; 19(3):219-27. PubMed ID: 10487959
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vitreous polyamines spermidine, putrescine, and spermine in human proliferative disorders of the retina.
    Nicoletti R; Venza I; Ceci G; Visalli M; Teti D; Reibaldi A
    Br J Ophthalmol; 2003 Aug; 87(8):1038-42. PubMed ID: 12881351
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Obesity accelerates endothelial-to-mesenchymal transition in adipose tissues of mice and humans.
    Chavkin NW; Vippa T; Jung C; McDonnell S; Hirschi KK; Gokce N; Walsh K
    Front Cardiovasc Med; 2023; 10():1264479. PubMed ID: 37795485
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intraocular expression of serum amyloid a and interleukin-6 in proliferative diabetic retinopathy.
    Ma Y; Tao Y; Lu Q; Jiang YR
    Am J Ophthalmol; 2011 Oct; 152(4):678-685.e2. PubMed ID: 21704966
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reduced Expression of Erythropoietin After Intravitreal Ranibizumab in Proliferative Diabetic Retinopathy Patients-Retrospective Interventional Study.
    Chen L; Feng J; Shi Y; Luan F; Ma F; Wang Y; Yang W; Tao Y
    Front Med (Lausanne); 2021; 8():710079. PubMed ID: 34621759
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.